Fifth revision to MDCG 2019-6 Guidance document released
Fifth revision to MDCG 2019-6 Guidance document released
Regulatory Affairs Medical Devices In Vitro Diagnostics
Wednesday, 05 March 2025
Kirsten Van Garsse, Authorized Representative Director & Regulatory Affairs Manager IVD
Share
\
\
X (Twitter) 
\
\
LinkedIn 
\
\
WhatsApp 
\
\
Copy link 
\
\
Mail
On February 7th, 2025, the Medical Device Coordination Group (MDCG) released a new revision of its guidance document containing Questions and Answers on requirements relating to notified bodies under Regulation (EU) 2017/745 (MDR) and Regulation (EU) 2017/746 (IVDR). This fifth revision of MDCG 2019-6 contains both new and updated questions and/or answers to questions.
Fifth revision to MDCG 2019-6 Guidance document released | QbD Group
2:09
MDCG 2019-6 Rev. 5: Questions and Answers on requirements relating to notified bodies.
What is new?
The fifth revision to MDCG 2019-6 splits two questions into sub-questions, updates the answers to five existing questions and introduces a new Q&A.
Compared to the previous version, more clarification is given with regards to the time period that notified personnel carrying out conformity assessment tasks need to take into account to avoid potential conflicts of interest with clients that they were previously associated with. The current revision also elaborates on what would be considered ‘consultancy’ by notified bodies, why conformity assessments can only be started after an application has been lodged, and what should be understood as ‘structured dialogue’ between a manufacturer and its notified body. Further, updated answers are provided relating to allocating notified body resources, acceptable time framefor surveillance audits and requirements for re-certification.
The new question addresses the leverage of evidence that was provided with previous applications by the manufacturer to that notified body. This should be addressed as part of the structural dialogue and may also apply to devices previously certified under the medical device directives.
What does it mean to you?
MDCG 2019-6 Rev.5 is important for notified bodies as well as MD and IVD manufacturers: it provides guidance on organisational, resource, process and quality management system requirements for notified bodies. Establishing a good understanding of these requirements is important for MD/IVD manufacturers when selecting, contracting and interacting with notified bodies under MDR or IVDR.
Discover more expert content
Previous
Regulatory Affairs
24 Dec 2024
MDCG 2022-3 Rev.1 released
Notified bodies are required to verify product batches of class D IVDs. Therefore, manufacturers...
Regulatory Affairs
10 Jan 2025
New MDCG 2020-16 Revision 3 Guidance Documents Released
MDCG 2020-16 Revision 3: Guidance on classification Rules for in vitro Diagnostic Medical Devices...
Regulatory Affairs
9 Jul 2024
MDCG: First Revision on the Guidance on Standardisation for Medical Devices
MDCG 2021-05 Revision 1: Guidance on standardization for medical devices The scope of this...
Regulatory Affairs
27 Jan 2025
Second revision to MDCG 2023-3 Guidance document released
MDCG 2023-3 Rev. 2: Questions and Answers on vigilance terms and concepts as outlined in the...
Regulatory Affairs
27 Jan 2025
New revisions of the Preliminary Assessment Review templates, forms and annexes
The documents are available in the Notified Body section of the MDCG Guidance webpage. The...
Regulatory Affairs
24 Dec 2024
MDCG 2022-3 Rev.1 released
Notified bodies are required to verify product batches of class D IVDs. Therefore, manufacturers...
Regulatory Affairs
10 Jan 2025
New MDCG 2020-16 Revision 3 Guidance Documents Released
MDCG 2020-16 Revision 3: Guidance on classification Rules for in vitro Diagnostic Medical Devices...
Regulatory Affairs
9 Jul 2024
MDCG: First Revision on the Guidance on Standardisation for Medical Devices
MDCG 2021-05 Revision 1: Guidance on standardization for medical devices The scope of this...
Regulatory Affairs
27 Jan 2025
Second revision to MDCG 2023-3 Guidance document released
MDCG 2023-3 Rev. 2: Questions and Answers on vigilance terms and concepts as outlined in the...
Regulatory Affairs
27 Jan 2025
New revisions of the Preliminary Assessment Review templates, forms and annexes
The documents are available in the Notified Body section of the MDCG Guidance webpage. The...
Regulatory Affairs
24 Dec 2024
MDCG 2022-3 Rev.1 released
Notified bodies are required to verify product batches of class D IVDs. Therefore, manufacturers...
Regulatory Affairs
10 Jan 2025
New MDCG 2020-16 Revision 3 Guidance Documents Released
MDCG 2020-16 Revision 3: Guidance on classification Rules for in vitro Diagnostic Medical Devices...
Next
- 1
- 2
- 3
Stay ahead in life sciences
Keeping up with the fast-paced life sciences industry doesn’t have to be overwhelming.
Our newsletter delivers the latest insights, industry updates, and expert content directly to your inbox, helping you stay informed and make smarter decisions.
Twitter Widget Iframe